Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price passed above its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Stock Performance
The company has a current ratio of 0.12, a quick ratio of 0.12 and a debt-to-equity ratio of 8.19. The company has a market cap of C$21.54 million and a P/E ratio of -12.66. The business’s 50 day simple moving average is C$2.00 and its 200 day simple moving average is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Recommended Stories
- Five stocks we like better than Liberty Biopharma
- REVEALED: Something Big Happening Behind White House Doors
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Elon Musk: This Could Turn $100 into $100,000
- Read this or regret it forever
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
